• EN/ES

    Orthopedics

    WebHealthNetwork : 2,378,479


  • Benefits & Savings

  • : ANCA-associated Vasculitis

ANCA-associated Vasculitis - 103 Studies Found

Not yet recruiting : Innovative Anti-pneumococcal Vaccine Strategies in Patients With ANCA-associated Vasculitis Receiving Rituximab Therapy
: Invasive Pneumococcal Infection
: 2017-02-27
:
  • Biological: PCV13 Other Name:

Not yet recruiting : Rituximab for ANCA-associated Vasculitis (RAVE) Long-Term Follow-Up Study
:
  • Granulomatosis With Polyangiitis
  • Microscopic Polyangiitis

: 2012-04-25
: Other: Observational Observational study of subjects previously enrolled in the RAVE trial
Active, not recruiting : Pilot Study of Short-Course Glucocorticoids and Rituximab for Treatment of ANCA-Associated Vasculitis
:
  • Granulomatosis With Polyangiitis
  • Microscopic Polyangiitis

: 2014-06-19
:
  • Drug: Glucocorticoids

Completed : Pulse Versus Continuous Cyclophosphamide for Induction of Remission in ANCA-Associated Vasculitides
:
  • ANCA Associated Systemic Vasculitis
  • Wegener's Granulomatosis
  • Granulomatosis, Wegener's
  • Microscopic Polyangiitis

: 2015-06-10
: Other: blood specimen blood specimen for serum rituximab level and serum anti-rituximab level at M1 and
Active, not recruiting : Comparison Study of Two Rituximab Regimens in the Remission of ANCA Associated Vasculitis
:
  • Granulomatosis With Polyangiitis
  • Microscopic Polyangiitis

  • : 2012-10-12
    :
    • Drug: Rituximab (Arm B) Rituxi

Terminated : The Clinical Efficacy of DFPP in Patients With AAGN
: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
: 2014-06-03
:
  • Other: DFPP&CTX

Completed : MMF Versus CTX in the Induction Treatment of ANCA Associated Vasculitis
:
  • Vasculitis
  • Anti-Neutrophil Cytoplasmic Antibody

: 2006-03-10
: Drug: mycophenolate mofetil MMF,1.0g/d Other Name: M
Withdrawn : Targeting Complement Activation in Antineutrophil Cytoplasmic Autoantibodies (ANCA)-Vasculitis - Eculizumab
: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
: 2010-12-13
:
  • Drug: Standard of care treatment

Withdrawn : Retinoids in ANCA Small Vessel Vasculitis: Silencing Autoantigens
: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
: 2011-01-10
:
  • Drug: Retinoic acid Patients w

<<< Previous | Next >>>
Orthopedics Health
Orthopedics Health WebHealth Network Media
  • WebHealthNetwork
  • DiabetesHealthMatters
  • HeartandStrokeHealth
  • WomensHealthCareCommunity
  • AsthmaHealthCenter
  • CancerHealthCenter
  • MentalHealthHelpCenter
  • Skincarehealthcenter
  • DigestiveTractHealth
  • VaccineHealthCenter
  • PainHealthCenter
  • FightingAddictionCenter
  • ObesityHealthMatters
  • SeniorHealthcareMatters
  • BrainAndNerveCenter
  • PediatricsHealthCenter
  • RareDiseasesHealthCenter
  • Wealth Mason
  • Home Owners Circle
  • EasyInsuranceFinder
  • EduJumpStart
  • SaleSpider
  • ScoopCafe
  • SaleSpiderMedia
  • Viewpoint.World
  • TravelerBooked
  • TechNewsBytes
  • Contact Us
  • Advertising Privacy Policy

This site uses cookies for analytics and advertising. No personal information is collected.

© Orthopedics Health .

We use cookies to enhance your experience, analyze anonymized traffic, and deliver personalized content and ads. No personal information is collected. By using our website, you consent to our use of cookies and agree to our data practices as described in our Privacy Policy. To Reject, please change your browser settings.